Hepatitis Monthly

Published by: Kowsar

The Prevalence of Hepatitis C Virus Infection and Its Related Risk Factors Among the Rural Population of Fars Province, Southern Iran

Mohammad Reza Fattahi 1 , Alireza Safarpour 1 , Masood Sepehrimanesh 1 , Seyed Mohammad Kazem Hosseini Asl 1 and Faezeh Mohamaddoust 1 , *
Authors Information
1 Gastroenterohepatology Research Center, Shiraz University of Medical Sciences, Shiraz, IR Iran
Article information
  • Hepatitis Monthly: February 15, 2015, 15 (2); e24734
  • Published Online: February 6, 2015
  • Article Type: Research Article
  • Received: October 20, 2014
  • Revised: December 1, 2014
  • Accepted: January 17, 2015
  • DOI: 10.5812/hepatmon.24734

To Cite: Fattahi M R, Safarpour A, Sepehrimanesh M, Hosseini Asl S M K, Mohamaddoust F. et al. The Prevalence of Hepatitis C Virus Infection and Its Related Risk Factors Among the Rural Population of Fars Province, Southern Iran, Hepat Mon. 2015 ;15(2):e24734. doi: 10.5812/hepatmon.24734.

Copyright: Copyright © 0, Hepatitis Monthly. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited..
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Shakeri MT, Nomani H, Ghayour Mobarhan M, Sima HR, Gerayli S, Shahbazi S, et al. The prevalence of hepatitis C virus in mashhad, iran: a population-based study. Hepat Mon. 2013; 13(3)[DOI][PubMed]
  • 2. Feldman M, Friedman L, Brandt L. Sleisenger and Fordtran's gastrointestinal and liver disease: pathophysiology, diagnosis, management, expert consult premium edition-enhanced online features. 2010;
  • 3. Alavian SM, Fallahian F. Epidemiology of hepatitis c in iran and the world. Semj. 2009; 10(4): 162-72
  • 4. Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology. 2013; 57(4): 1333-42[DOI][PubMed]
  • 5. Alavian SM, Ahmadzad-Asl M, Lankarani KB, Shahbabaie MA, Kabir A. Hepatitis C infection in the general population of Iran: a systematic review. Hepat Mon. 2009; 9(3): 211-23
  • 6. Jahanbakhsh Sefidi F, Keyvani H, Monavari SH, Alavian SM, Fakhim S, Bokharaei-Salim F. Distribution of hepatitis C virus genotypes in Iranian chronic infected patients. Hepat Mon. 2013; 13(1)[DOI][PubMed]
  • 7. Rosenthal E, Hazani A, Segal D, Koren A, Kamal S, Rimon N, et al. Lack of transmission of hepatitis C virus in very close family contacts of patients undergoing multitransfusions for thalassemia. J Pediatr Gastroenterol Nutr. 1999; 29(1): 101-3[DOI][PubMed]
  • 8. Iwarson S, Norkrans G, Wejstal R. Hepatitis C: natural history of a unique infection. Clin Infect Dis. 1995; 20(5): 1361-70[PubMed]
  • 9. Flynn JK, Sacks-Davis R, Higgs P, Aitken C, Moneer S, Suppiah V, et al. Detection of HCV-Specific IFN-gamma Responses in HCV Antibody and HCV RNA Negative Injecting Drug Users. Hepat Mon. 2014; 14(1)[DOI][PubMed]
  • 10. Larney S, Kopinski H, Beckwith CG, Zaller ND, Jarlais DD, Hagan H, et al. Incidence and prevalence of hepatitis C in prisons and other closed settings: results of a systematic review and meta-analysis. Hepatology. 2013; 58(4): 1215-24[DOI][PubMed]
  • 11. Tamaddoni A, Mohammadzadeh I, Ziaei O. Seroprevalence of HCV antibody among patients with beta-thalassemia major in Amirkola Thalassemia Center, Iran. Iran J Allergy Asthma Immunol. 2007; 6(1): 41[PubMed]
  • 12. Ditah I, Ditah F, Devaki P, Ewelukwa O, Ditah C, Njei B, et al. The changing epidemiology of hepatitis C virus infection in the United States: National Health and Nutrition Examination Survey 2001 through 2010. J Hepatol. 2014; 60(4): 691-8[DOI][PubMed]
  • 13. Bruggmann P, Berg T, Ovrehus AL, Moreno C, Brandao Mello CE, Roudot-Thoraval F, et al. Historical epidemiology of hepatitis C virus (HCV) in selected countries. J Viral Hepat. 2014; 21 Suppl 1: 5-33[DOI][PubMed]
  • 14. Hope VD, Eramova I, Capurro D, Donoghoe MC. Prevalence and estimation of hepatitis B and C infections in the WHO European Region: a review of data focusing on the countries outside the European Union and the European Free Trade Association. Epidemiol Infect. 2014; 142(2): 270-86[DOI][PubMed]
  • 15. Quoilin S, Hutse V, Vandenberghe H, Claeys F, Verhaegen E, De Cock L, et al. A population-based prevalence study of hepatitis A, B and C virus using oral fluid in Flanders, Belgium. Eur J Epidemiol. 2007; 22(3): 195-202[DOI][PubMed]
  • 16. Pereira LM, Martelli CM, Moreira RC, Merchan-Hamman E, Stein AT, Cardoso MR, et al. Prevalence and risk factors of Hepatitis C virus infection in Brazil, 2005 through 2009: a cross-sectional study. BMC Infect Dis. 2013; 13: 60[DOI][PubMed]
  • 17. Rotermann M, Langlois K, Andonov A, Trubnikov M. Seroprevalence of hepatitis B and C virus infections: Results from the 2007 to 2009 and 2009 to 2011 Canadian Health Measures Survey. Health Rep. 2013; 24(11): 3-13[PubMed]
  • 18. Nemecek V, Castkova J, Fritz P, Linhartova A, Svandova E, Sramova H, et al. The 2001 serological survey in the Czech Republic--viral hepatitis. Cent Eur J Public Health. 2003; 11 Suppl-61[PubMed]
  • 19. Christensen PB, Hay G, Jepsen P, Omland LH, Just SA, Krarup HB, et al. Hepatitis C prevalence in Denmark -an estimate based on multiple national registers. BMC Infect Dis. 2012; 12: 178[DOI][PubMed]
  • 20. Ray SC, Arthur RR, Carella A, Bukh J, Thomas DL. Genetic epidemiology of hepatitis C virus throughout egypt. J Infect Dis. 2000; 182(3): 698-707[DOI][PubMed]
  • 21. Harris RJ, Ramsay M, Hope VD, Brant L, Hickman M, Foster GR, et al. Hepatitis C prevalence in England remains low and varies by ethnicity: an updated evidence synthesis. Eur J Public Health. 2012; 22(2): 187-92[DOI][PubMed]
  • 22. Volzke H, Schwahn C, Wolff B, Mentel R, Robinson DM, Kleine V, et al. Hepatitis B and C virus infection and the risk of atherosclerosis in a general population. Atherosclerosis. 2004; 174(1): 99-103[DOI][PubMed]
  • 23. Sola R, Cruz De Castro E, Hombrados M, Planas R, Coll S, Jardi R, et al. [Prevalence of hepatitis B and hepatitis C viruses in different counties of Catalonia, Spain: cross-sectional study]. Med Clin (Barc). 2002; 119(3): 90-5[PubMed]
  • 24. Sagmeister M, Renner EL, Mullhaupt B, Wong JB. Simulation of hepatitis C based on a mandatory reporting system. Eur J Gastroenterol Hepatol. 2002; 14(1): 25-34[PubMed]
  • 25. Tozun N, Ozdogan OC, Cakaloglu Y, Idilman R, Karasu Z, Akarca US. A nationwide prevalence study and risk factors for hepatitis A, B, C and D infections in Turkey. Turkish Association for the Study of the Liver. 2010; 32(3)
  • 26. Merat S, Rezvan H, Nouraie M, Jafari E, Abolghasemi H, Radmard AR, et al. Seroprevalence of hepatitis C virus: the first population-based study from Iran. Int J Infect Dis. 2010; 14 Suppl 3-6[DOI][PubMed]
  • 27. Ahmad A. B. , Keeffe E. Hepatitis C virus infection. In: Yamada TH, Alpers DN, Kalloo A, Kaplowitz N, editors. Textbook of gastroenterology. 2009;
  • 28. Kohan N, Zandieh T, Samiei SH, Ataie Z, Kavari M. The prevalence and clinical significance of hepatitis B and C coinfection. Iran J Med Sci. 2006;
  • 29. Assarehzadegan MA, Ghafourian Boroujerdnia M, Zandian K. Prevalence of hepatitis B and C infections and HCV genotypes among haemophilia patients in ahvaz, southwest iran. Iran Red Crescent Med J. 2012; 14(8): 470-4[PubMed]
  • 30. Borhany M, Shamsi T, Boota S, Ali H, Tahir N, Naz A, et al. Transfusion transmitted infections in patients with hemophilia of Karachi, Pakistan. Clin Appl Thromb Hemost. 2011; 17(6): 651-5[DOI][PubMed]
  • 31. El-Faramawy AA, El-Rashidy OF, Tawfik PH, Hussein GH. Transfusion transmitted hepatitis: where do we stand now? A one center study in upper egypt. Hepat Mon. 2012; 12(4): 286-91[DOI][PubMed]
  • 32. Gonzalez R, Torres P, Castro E, Barbolla L, Candotti D, Koppelman M, et al. Efficacy of hepatitis B virus (HBV) DNA screening and characterization of acute and occult HBV infections among blood donors from Madrid, Spain. Transfusion. 2010; 50(1): 221-30[DOI][PubMed]
  • 33. Haidar NA. Prevalence of hepatitis B and hepatitis C in blood donors and high risk groups in Hajjah, Yemen Republic. Saudi Med J. 2002; 23(9): 1090-4[PubMed]
  • 34. Elizee PK, Alavian SM, Miri SM, Behnava B, Alavian SH, Keshvari M, et al. The seroprevalence of entrically transmitted viral hepatitis in hcv infected thalassemia and hemophilia patients in iran. Jundishapur J Microb. 2013; 6(7)
  • 35. Arababadi MK, Nasiri Ahmadabadi B, Yousefi Daredor H, Kennedy D. Epidemiology of occult hepatitis B infection among thalassemic, hemophilia, and hemodialysis patients. Hepat Mon. 2012; 12(5): 315-9[DOI][PubMed]
  • 36. Khattak MF, Salamat N, Bhatti FA, Qureshi TZ. Seroprevalence of hepatitis B, C and HIV in blood donors in northern Pakistan. J Pak Med Assoc. 2002; 52(9): 398-402[PubMed]
  • 37. Mittal M, Zaman S, Bhatnagar N, Gajjar M. Transfusion transmitted infections in patients with hemophilia: A study from a tertiary care hospital in western india. IJID . 2013; 12(1)
  • 38. Orman ES, Fried MW. Hepatitis C viral infection in patients with hemophilia and hemolytic disorders. Clin Liver Dis. 2012; 1(3): 95-7
  • 39. Valizadeh N, Nateghi S, Noroozi M, Hejazi S, Aghanezhad F, Ali AA. Seroprevalence of hepatitis C, hepatitis B and HIV viruses in hemophiliacs born 1985-2010 in west Azarbaijan of Iran. Asian J Transfus Sci. 2013; 7(1): 55-8[DOI][PubMed]
  • 40. Yazdani MR, Kassaian N, Ataei B, Nokhodian Z, Adibi P. Hepatitis C virus infection in patients with hemophilia in Isfahan, Iran. Int J Prev Med. 2012; 3-93[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader